Mivacron (Mivacurium Chloride)

Mivacurium chloride, the active ingredient in Mivacron, is a non-depolarizing neuromuscular blocker presented as an injectable solution for intravenous use. It provides skeletal muscle relaxation to facilitate endotracheal intubation, support surgical procedures, and assist mechanical ventilation in adult patients. It is marketed in the European Union and is administered under controlled clinical settings.

GNH USA supplies Mivacron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia, Africa and the Americas.

Mivacron, a non-depolarizing neuromuscular blocker, is used in clinical situations that require rapid and reversible skeletal muscle relaxation.

- Endotracheal intubation: facilitates safe placement of the airway tube by providing short‑acting muscle relaxation. - Surgical procedures: provides skeletal muscle relaxation to improve operative conditions during general anesthesia. - Mechanical ventilation: serves as an adjunct to enable controlled ventilation in patients requiring respiratory support.

Mivacron may be associated with a range of adverse reactions